United States· US:72603-107_1abbe952-58bc-4dbc-b06a-fb79167bcd66

Decitabine

A decitabine product containing decitabine, registered in United States by Northstar Rx LLC. The same ATC class is registered in 14 of our 19 countries.

ATC L01BC08US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDecitabineATCL01BC08REGISTER NO.US:72603-107_1abbe952…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Decitabine is registered in 14 of 19 countries.

Countries holding a registration under ATC L01BC08 (decitabine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose

Decitabine · ATC L01BC08

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of decitabine costs, country by country.

Normalised to the WHO defined daily dose (6.43 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Decitabine · price per daily dose (6.43 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$137.43
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DECITABINE
Manufacturer
Northstar Rx LLC
Country
United States (US)
ATC code
L01BC08
ATC class
Decitabine
Defined daily dose
6.43 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    72603-107-01
  • ndc11
    7260310701
    1 VIAL, SINGLE-DOSE in 1 CARTON (72603-107-01) / 10 mL in 1 VIAL, SINGLE-DOSE

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

112 interactions on record for decitabine.

Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Decitabine · interactions on record

112 records

  • 30 severe
  • 82 moderate

Most severe, free to view

  • CladribineL01BB04severe
  • Talimogene laherparepvecL01XL02severe
  • Talimogen laherparepvecL01XX51severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Decitabine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All decitabine products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Decitabin Accord, Decitabine Ever Pharma
  • Belgium · Decitabine Ever Pharma, Decitabine Hikma
  • Bulgaria · Децитабин Ever Pharma
  • Cyprus · Decitabine Accord, Decitabine Teva
  • Denmark · Decitabin Teva, Decitabine "sandoz"
  • Spain · Decitabina Accord, Decitabina Eugia
  • Finland · Decitabine Ever Pharma
  • United Kingdom (Northern Ireland) · Decitabine Hikma Farmacêutica (Portugal)
  • Croatia · Decitabin Accord, Decitabine Ever Pharma
  • Hungary · Decitabine Ever Pharma
  • Ireland · Decitabine Accord, Decitabine Ever Pharma
  • Iceland · Dacogen
  • Italy · Decitabina Accord, Decitabina Aurobindo
  • Liechtenstein · Dacogen
  • Lithuania · Decitabine Accord, Decitabine Ever Pharma
  • Latvia · Decitabine Ever Pharma
  • Netherlands · Decitabine Ever Pharma, Decitabine Hikma
  • Norway · Dacogen, Decitabin Teva
  • Portugal · Decitabina Accord, Decitabina Eugia
  • Romania · Decitabină Accord, Decitabină Sandoz
  • Sweden · Decitabin Teva, Decitabine Accord
  • Slovenia · Decitabin Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fdd0d358-3109-48f8-b5ab-9186c427d5aa
GET /v1/drugs/fdd0d358-3109-48f8-b5ab-9186c427d5aa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "50",
  "substance": "DECITABINE",
  "productndc": "72603-107",
  "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/10mL",
  "application_number": "ANDA212265",
  "marketing_category": "ANDA"
}

See everything about decitabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.